Beyond Disease

Our Beyond Disease theme examines how developments in biomedicine challenge established ideas about particular diseases and raises questions about what counts as disease and how disease fits within society and culture.

Theme Summary

The way disease is understood shapes how we organise and deliver healthcare. It shapes how biomedical science is managed and funded, and which kinds of knowledge are considered important and relevant to health. This impacts individuals’ experiences of health and illness in unique ways.  For example, new understanding of tumours in cancer research brings new treatment options and disrupts conventional schemes of classification. Meanwhile, population research into cancer biomarkers leads to new categories of risk, bringing new ‘patients-in-waiting’ under medical management.  

Our Beyond Disease theme engages debates over disability, normality, ‘naturalness’, and enhancement and challenges concepts of disease and therapy. Using academic research, public engagement, and rapid-response papers, the theme interrogates increasing costs, earlier preventive interventions, and ever-multiplying ways individuals seek to access biomedical technologies add uncertainty to what counts as health, illness, and disease - and who benefits from those labels. 

Our core research questions include:

  • What is the nature of disease in contemporary societies?
  • Who has the authority to label particular diseases?
  • What is the subjective significance of disease classification?
  • What frameworks can we use to interrogate the idea of disease?

 

Engagement and Outputs

 

Theme leads

Martyn Pickersgill

Steve Sturdy

Researchers and partners

Sarah Chan

Giulia De Togni

Sonja Erikainen

Angela Marques Filipe

Andrea Ford

Esther Gonzalez Hernando

Chase Ledin

Ago Ganguli Mitra

Julia Swallow

Ingrid Young